Successful Biotech Investing: Every Investor's Complete Guide

by Joe Duarte

Medical biotechnology is a multibillion dollar global industry, and is growing rapidly. Breakout companies worldwide present highly profitable investment opportunities, but many investors avoid the sector because the science is difficult to understand and the opportunities easy to miss. Where can the layperson find reliable, fundamental information about biotechnology in order to make informed investment decisions?In Successful Biotech Investing,...

• Format: Hardcover
• Language: English
• ISBN: 076153301X
• ISBN13: 9780761533016
• Release Date: May 2001
• Publisher: Prima Lifestyles
• Length: 416 Pages
• Weight: 1.60 lbs.
• Dimensions: 1.3" x 6.3" x 9.3"

Customer Reviews

great foundation for aspiring biotech investors

This book provides the average investor with a solid foundation in their pursuit of successful biotech investing. Most investors invest in biotech stocks based on media exposure and momentum driven markets. There is a glaring lack of any sort of structure to their research or position management. Dr. Duarte's book lays the groundwork for investors to establish a workable system of identifying and managing promising investments. By incorporating risk management techniques (technical analysis), he has provided a dose of reality to balance the inherent optimism the motivates biotech investors. This is crucial as it prevents the blow ups that destroy portfolios as well as investor confidence.

Finally! A book that helps the average investor in biotech

Since I'm not interested in being a PhD this seems like the perfect book for me and more than likely for the average investor. The thing I really like about this book is that it helps me know how to make money from the coming biotech explosion. I don't care how this stuff works nearly as much as how to build my net worth by investing. On that point, this is THE book. It has just about everything-understandable explanation of the industry, how to tell which companies are likely to be leaders, and even a reference database. If I had a book this good at the beginning of the 'high tech' explosion I could have retired already. I would have understood enough about Oracle, Cisco, and all that lot to make even more money. I don't intend to be on the back half of the next wave. I give this book five stars. Thanks a million, $$$, to the author.

Successful Biotech Investing

Dr. Duarte has put it all together in this book. The future of biotech stocks is incredible, but investing without a full understanding of the industry is risky. All the knowledge you need to invest successfully in biotech issues is right here!

Good Basic Introduction to Biotechnology Investing

Dr. Duarte is an anesthesiologist, a professional stock commentator and an investment advisor. In this book he seeks to "bring stock picking and science together." The book gives you a basic scientific background of the biotechnology industry, describes the way that the industry is regulated in creating new drugs, profiles the leading pharmaceutical and biotechnology companies, proposes a way to evaluate the fundamental performance of each company, and describes the ways that you can use technical analysis to pick when to buy and sell these stocks. This helpful information is provided against the context of the wild swings in stock prices as the overall market and general news move stock price levels. He begins by pointing out that the statement by President Clinton and Prime Minister Blair that the rights of biotechnology companies should be restricted was a short-term storm, but a long-term non-event. Such moments provide buying opportunities. The book has two basic weaknesses. First, it fails to point out that most people should avoid biotechnology stocks. They should be very volatile, and can have stomach-churning drops that will cause many investors to sell at the worst times. The vast majority of ordinary investors should be buying broad-based index funds (see Common Sense on Mutual Funds). Second, the book fails to point out that the rate of discoveries in any given company should be slowing down in the future. This is because after a company is public, it will usually limit R & D to try to create a profit track record and because the science is simply more difficult and lengthy as more proteins and enzymes become involved in solutions. As a result, we could see very long time periods when investments will be under water. If you have a multiple-year time horizon (such as being under 40), he is probably right that "big bucks are possible for those who see beyond the short-term setbacks in biotechnology." On the other hand, this should probably be a small part of your portfolio, even then.After you have read and learned from this book, I suggest that you think about your emotional profile as an investor. How have and are you likely to react to taking large losses? What percentage of the time do you need to see your stocks be ahead before you are comfortable? How much money do your feel comfortable losing in the short-term in one stock? These are important questions that will have a large impact on your success in stock investing. May you meet your finanical goals!